Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05200182
Other study ID # 35RC20_9849_Cemov
Secondary ID 2021-A02314-37
Status Recruiting
Phase N/A
First received
Last updated
Start date April 7, 2022
Est. completion date May 2025

Study information

Verified date April 2024
Source Rennes University Hospital
Contact Loïc JACOB
Phone 0299282555
Email loic.jacob@chu-rennes.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Emotional overeating is characterized by an excessive food intake in the context of intense emotional situations, such as acute stress one. Emotional overeating, as a behavioral trait, can increase the risk of to develop eating disorders or eating-related diseases, such as metabolic syndrome, obesity, type-2 diabetes. Recently, imaging modalities, such as magnetic resonance imaging (MRI) and electro-encephalography (EEG), have been adapted in order to perform neurofeedback consisting on presenting the brain activity instantaneously to the participant, that give him the possibility to modify this activity by his own mean. Neurofeedback has already shown some efficacy, either with explicit or implicit instruction. Compared with functional MRI (fMRI), functional near infra-red spectroscopy (fNIRS) is easy to handle, less expensive, and does not require a lying position. fNIRS is consequently more adapted for repeated acquisitions. Neurofeedback has already shown some promising results for neurological and psychiatric diseases. For mental states and emotion regulation, neurofeedback targeting the prefrontal cortex (PFC) has also shown promising outcomes. In this project, the investigators want to assess the effect of neurofeedback targeting the dorsolateral PFC (dlPFC) in a population of young adult women presenting emotional overeating. The investigators aim to improve the cognitive control and to reduce the episodes of emotional overeating in order to prevent the occurrence of subsequent pathologies. The intervention effect will be characterized with: (i) fMRI in order to evaluate the effect on cognitive control (with resting state fMRI or rsMRI) and on the reward system; (II) questionaries directly and one month after intervention in order to assess the behavioral effect. Besides an expected effect on emotional overeating, the investigators will evaluate whether an improvement of cognitive control can also promote positive effect on other behavioral traits that could lead to some pathologies such as food addiction. As a prerequisite to this study on emotional overeating (study B), the investigators will firstly validate on healthy subjects (study A) a reward anticipation fMRI task, which will be further used in study A in order to characterized the effect of neurofeedback on the reward system.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date May 2025
Est. primary completion date May 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Eligibility Study A : - Minimum age : 18 Years - Maximum Age : 50 Years - Sex : women or men Inclusion Criteria : - Normal Body Mass Index (18.5-25), - Right-handlers - Affiliated to a social security scheme - Having given a free, informed and written consent Exclusion Criteria : Related to the study - Insufficient command of French Related to Magnetic Resonance Imagine - Implantable cardiac pacemaker or defibrillator; - Neurosurgical clips; - Cochlear implants; - Neural or peripheral stimulator; - Foreign orbital or brain metallic foreign bodies; - Endoprostheses implanted for less than 4 weeks and osteosynthesis materials placed for less than 6 weeks; - Claustrophobia. Related to near infra Red spectroscopy - Hairs that do not allow proper near infra Red spectroscopy measurement upon ligh blockage Study B - Minimum age : 18 Years - Maximum Age : 25 Years - Sex : women Inclusion Criteria : - Normal BMI (18.5-25), - Right-handlers - Affiliated to a social security scheme - Having given a free, informed and written consent - Based on emotional overeating questionary : having emotional overeating episodes > 6 days in a month for at least one negative emotion Exclusion Criteria : Related to the study - Insufficient command of French - Excessive consumption of alcohol or other psychoactive substances (determined on the basis of the Alcohol Use Disorders Identification Test questionnaires - excluded if score > 12 and "Car, Relax, Alone, Forget, Friends, Trouble" questionnaire - excluded if score> 1 " yes ") - Eating disorders ("sick, control, one stone, fat, food" questionnaire >2) - Food addiction (Yale Food Addiction Score 2.0, score >2 - With psychoactive treatment - Digestive or gastric disorders Related to magnetic resonance imaging - Implantable cardiac pacemaker or defibrillator; - Neurosurgical clips; - Cochlear implants; - Neural or peripheral stimulator; - Foreign orbital or brain metallic foreign bodies; - Endoprostheses implanted for less than 4 weeks and osteosynthesis materials placed for less than 6 weeks; - Claustrophobia. Related to near infraRed spectroscopy - Hairs that do not allow proper near infraRed spectroscopy measurement upon ligh blockage

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Neurofeedback with functional near infra-red spectroscopy
the neurofeedback protocol will last 15 minutes per session, and during each session, the volunteer will have to increase the brain activity of his/her dorsolateral prefrontal cortex using a visual gauge representing the "activity level" of his/her own dorsolateral prefrontal cortex. No specific instructions will be given to the volunteer so that he/she can develop his/her own internal strategy to increase this "activity level".
Sham Neurofeedback
the participants will receive the same instruction but will be shown a random signal
Other:
oral microbiota collection
an examination and oral swab for oral microbiota analysis will be performed by a dentist
Questionnaires
questionnaires for pre-intervention behavioral characterization
Device:
resting-state fMRI
characterize the brain function of volunteers by resting-state fMRI
Electro gastrogram
Volunteers will also be equipped with an MRI-compatible electro-gastrogram device to correlate gastric signals with brain activity during rsMRI acquisition.
Behavioral:
Emotional Stroop task
an emotional Stroop task adapted to food and body image representation

Locations

Country Name City State
France Chu Rennes - Pontchaillou Rennes

Sponsors (2)

Lead Sponsor Collaborator
Rennes University Hospital Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in cortico-striatal connectivity Significant change in cortico-striatal connectivity as determined with resting state functional magnetic resonance imaging correlation coefficient between the first magnetic resonance imaging and the last magnetic resonance imaging visit 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT02629991 - Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome Phase 2
Recruiting NCT05939453 - Impact of Bright Light Therapy on Prader-Willi Syndrome N/A
Terminated NCT03790865 - Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome Phase 2/Phase 3
Completed NCT03375853 - Computerized Response Training Obesity Treatment N/A
Completed NCT04150991 - Fiber Intervention on Gut Microbiota in Children With Prader-Willi Syndrome N/A
Recruiting NCT06239064 - Early Genetic Identification of Obesity
Recruiting NCT05044000 - Effect of Deep Propioceptive Stimulation in Prader-Willi Syndrome N/A
Terminated NCT00175305 - Prader-Willi Syndrome and Appetite Phase 3
Recruiting NCT02758262 - Effects of Noninvasive Brain Stimulation on Brain Activity and Appetite N/A
Completed NCT01863017 - Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome N/A
Recruiting NCT03197662 - Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome Phase 2